InvestorsObserver
×
News Home

Will Acurx Pharmaceuticals Inc (ACXP) Beat the Rest of the Stocks in the Healthcare Sector?

Friday, October 27, 2023 01:44 PM | InvestorsObserver Analysts

Mentioned in this article

Will Acurx Pharmaceuticals Inc (ACXP) Beat the Rest of the Stocks in the Healthcare Sector?

A rating of 99 puts Acurx Pharmaceuticals Inc (ACXP) near the top of the Healthcare sector according to InvestorsObserver. Acurx Pharmaceuticals Inc's score of 99 means that it ranks higher than 99% of stocks in the sector. In addition, its overall score of 79 ranks it higher than 79% of all stocks.

Overall Score - 79
ACXP has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on ACXP!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Acurx Pharmaceuticals Inc Stock Today?

Acurx Pharmaceuticals Inc (ACXP) stock has gained 15.06% while the S&P 500 has fallen -0.5% as of 1:42 PM on Friday, Oct 27. ACXP has gained $0.71 from the previous closing price of $4.72 on volume of 435,716 shares. Over the past year the S&P 500 has risen 8.12% while ACXP has gained 71.84%. ACXP lost -$1.13 per share the over the last 12 months. Click Here to get the full Stock Report for Acurx Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App